2012Yixue yanjiusheng xuebaoRequires access

Antidepressant effect of NMDA receptor and its sub-receptor antagonists in rats

Jianguo Xu

Open publisher page 0 citations

Abstract

Objective The ion receptor drugs relieve the symptons of depression,while the mechanism for this effect is unclear.The aim of this study is to investigate the effect of the N-Methyl-D-aspartate(NMDA) receptor and its sub-receptor antagonists on the immobility time and expression of the hippocampual brain-derived neurotrophic factor(BDNF) in rats receiving the forced swimming test(FST).Methods Forty male Wistar rats were equally randomized to four groups.After insulted in FST for 15 min on the previous day,the rats were intraperitoneally injected with 1 ml of saline(the S group),5 mg/kg of NVP-AAM077(NR2B receptor antagonist)(the NVP group),5 mg/kg of ketamine(NMDA receptor antagonist)(the Ket group),and 10 mg/kg of Ro25-6981(NR2B receptor antagonist)(the Ro group),respectively.Thirty minutes later,the immobility time of the rats receiving FST was recorded,and the hippocampus tissue was harvested for detection of the level of BDNF.Results Compared with the rats in the S group,those in the NVP group exhibited no significant changes either in the immobility time nor in the expression of hippocampual BDNF(P0.05),whereas the Ket and Ro groups showed a remarkable decrease in the immobility time and an increase in the expression of hippocampual BDNF(P0.05).Conclusion Both Ketamine and Ro25-6981 have an antidepressant effect,which may be related to the upregulated expression of hippocampual BDNF.

About this research paper

What this paper is about

Objective The ion receptor drugs relieve the symptons of depression,while the mechanism for this effect is unclear.The aim of this study is to investigate the effect of the N-Methyl-D-aspartate(NMDA) receptor and its sub-receptor antagonists on the immobility time and expression of the hippocampual brain-derived neurotrophic factor(BDNF) in rats receiving the forced swimming test(FST).Methods Forty male Wistar rats were equally randomized to four groups.After insulted in FST for 15 min on the previous day,the rats were intraperitoneally injected with 1 ml of saline(the S group),5 mg/kg of NVP-AAM077(NR2B receptor antagonist)(the NVP group),5 mg/kg of ketamine(NMDA receptor antagonist)(the Ket group),and 10 mg/kg of Ro25-6981(NR2B receptor antagonist)(the Ro group),respectively.Thirty minutes later,the immobility time of the rats receiving FST was recorded,and the hippocampus tissue was harvested for detection of the level of BDNF.Results Compared with the rats in the S group,those in the NVP group exhibited no significant changes either in the immobility time nor in the expression of hippocampual BDNF(P0.05),whereas the Ket and Ro groups showed a remarkable decrease in the immobility time and an increase in the expression of hippocampual BDNF(P0.05).Conclusion Both Ketamine and Ro25-6981 have an antidepressant effect,which may be related to the upregulated expression of hippocampual BDNF.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective The ion receptor drugs relieve the symptons of depression,while the mechanism for this effect is unclear.The aim of this study is to investigate the effect of the N-Methyl-D-aspartate(NMDA) receptor and its sub-receptor antagonists on the immobility time and expression of the hippocampual brain-derived neurotrophic factor(BDNF) in rats receiving the forced swimming test(FST).Methods Forty male Wistar rats were equally randomized to four groups.After insulted in FST for 15 min on the previous day,the rats were intraperitoneally injected with 1 ml of saline(the S group),5 mg/kg of NVP-AAM077(NR2B receptor antagonist)(the NVP group),5 mg/kg of ketamine(NMDA receptor antagonist)(the Ket group),and 10 mg/kg of Ro25-6981(NR2B receptor antagonist)(the Ro group),respectively.Thirty minutes later,the immobility time of the rats receiving FST was recorded,and the hippocampus tissue was harvested for detection of the level of BDNF.Results Compared with the rats in the S group,those in the NVP group exhibited no significant changes either in the immobility time nor in the expression of hippocampual BDNF(P0.05),whereas the Ket and Ro groups showed a remarkable decrease in the immobility time and an increase in the expression of hippocampual BDNF(P0.05).Conclusion Both Ketamine and Ro25-6981 have an antidepressant effect,which may be related to the upregulated expression of hippocampual BDNF.

Key concepts: NMDA receptor, Behavioural despair test, Antagonist, Brain-derived neurotrophic factor, Receptor antagonist, Endocrinology, Neurotrophic factors, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Antidepressant effect of NMDA receptor and its sub-receptor antagonists in rats — Research Paper | ScholarLens